+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07726771

Randomized Trial Comparing Dye-Based and Virtual Chromoendoscopy During Surveillance Pouchoscopy in Adults with Familial Adenomatous Polyposis

Led by London North West Healthcare NHS Trust · Updated on 2026-07-24

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an international, multicenter randomized controlled trial to compare two methods of chromoendoscopydye-based and virtual chromoendoscopy using narrow-band or blue-light imagingfor detecting adenomas during routine surveillance pouchoscopy in adults with familial adenomatous polyposis FAP who have undergone ileal pouch-anal anastomosis IPAA. The study aims to provide evidence to standardize surveillance practices, as current guidelines allow both techniques but do not recommend a preferred method. The trial will enroll adults aged 18 years and older with FAP confirmed by genetic or clinical diagnosis. Participants will be randomly assigned to either the dye-based chromoendoscopy group, where indigo carmine dye is applied to enhance mucosal visualization, or the virtual chromoendoscopy group, which uses optical or digital image enhancement without dye. During surveillance pouchoscopy, endoscopists will examine the pre-pouch ileum, pouch body, and rectal cuff, documenting adenomas by size and location. Adenomas meeting certain size or suspicion criteria will be removed using standard polypectomy techniques during the same procedure. Endoscopic images will be collected to assess measurement reliability. Participants will undergo their usual scheduled pouchoscopy performed by experienced endoscopists. Data collected will include quality parameters like bowel preparation and procedure duration. Follow-up care will follow routine clinical practice, with participants monitored for adverse events after pouchoscopy. The study will measure the incidence of clinically relevant adenomas larger than 5 mm as the primary outcome, along with secondary outcomes related to adenoma characteristics and procedure details. Data will be securely managed and analyzed over a study period of approximately two years.

CONDITIONS

Brief Title

Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)

Research Team

A

Andrew Latchford, MBBS PhD FRCP

B

Benjamin Zare, MBChB (Hons) MRCP

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here